amazon facebook_32 gplus_32 linkedin_32 pinterest_32 tumblr_32 twitter_32 website_32 youtube_32 email_32 rss_32

MySocialGoodNews is dedicated to sharing news about
social entrepreneurship, impact investing, philanthropy
and corporate social responsibility.

Crowdfunding for Social Good

Devin D. Thorpe

Devin Thorpe

Annual Lung Cancer Gala Celebrates New Hope and Scientific Progress

NYC Business Leaders, Philanthropists, and Survivors Gathered during Lung Cancer Awareness Month to Support Lung Cancer Research

Press Release – Washington, DC (Nov. 3, 2017) – On Thursday, Nov. 2, LUNGevity Foundation, the nation’s leading lung cancer focused organization, brought together New York City’s top business leaders, researchers, philanthropists and lung cancer survivors for the Foundation’s fifth annual Celebration of HOPE Gala at the Mandarin Oriental New York. Emceed by NBC 4 11 a.m. and 4 p.m. Weather Anchor Dave Price, the gala spotlighted the unprecedented progress in lung cancer research that is giving survivors reason to hope. The evening included the presentation of awards honoring 27-year-old lung cancer survivor and advocate Amanda Kouri and Jill DeSimone, Senior Vice President, US Oncology, Merck, who accepted the award on her company’s behalf. Both were recognized for their contributions to the lung cancer community.

Gala Vice Chairs Alexander Stern, Chief Operating Officer, Chief Executive Officer-Financial Advisory, Lazard and Peter Babej, Global Head of Financial Institutions, Citigroup / Global Banking; Gala Honorary Chair Lynne Doughtie, Chairman and CEO KPMG LLP; and Dinner Chairs Rosemary and James Marquardt were among many New York business leaders and philanthropists in attendance.

About LUNGevity Foundation

LUNGevity is the nation’s leading lung cancer organization investing in lifesaving, translational research and providing support services and education for patients and caregivers. LUNGevity’s goals are three-fold: (1) accelerate research to patients, (2) empower patients to be active participants in their treatment decisions, and (3) remove barriers that patients face in accessing the right treatments.

LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. LUNGevity’s comprehensive resources include a medically vetted website, a toll-free Help Line in partnership with CancerCare®, a unique lung cancer navigator app, peer-to-peer matching for patients and caregivers (LUNGevity LifeLine), and survivorship conferences. LUNGevity also helps patients find and navigate clinical trials through our clinical trial finder tool, a Clinical Trial Ambassador program, and participation with Emerging Med.

Our vision is a world where no one dies of lung cancer. For more information about LUNGevity Foundation, please visit

About Lung Cancer in the U.S.

  • About 1 in 16 Americans will be diagnosed with lung cancer in their lifetime
  • More than 224,000 people in the U.S. will be diagnosed with lung cancer this year
  • About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
  • Lung cancer takes more lives than the next four deadliest cancers (colorectal, pancreatic, breast, and prostate) combined
  • Only 18% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it’s caught before it spreads, the chance for 5-year survival improves dramatically

Never miss another article! Join Devin here:

Don't miss any Good News!
Subscribe to news from!
* = required field
Content I want:

Find Us On

amazon facebook_32 gplus_32 linkedin_32 pinterest_32 tumblr_32 twitter_32 website_32 youtube_32 email_32 rss_32